Success Metrics

Active Trials
2(67%)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown133%
recruiting267%

Recent Activity

2 active trials
Showing 3 of 3
recruiting

An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.

NCT07182214
recruitingnot_applicable

Pyrophosphate and Arterial Calcification in Chronic Kidney Disease

NCT04950439
unknownnot_applicable

The Population Pharmacokinetics Study of Tigecycline and Pharmacokinetics- Pharmacodynamics Index in Patients With Carbapenem Resistant Enterobacteriaceae Bloodstream Infection

NCT06049771

Clinical Trials (3)

Showing 3 of 3 trials
NCT07182214

An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.

Recruiting
NCT04950439Not Applicable

Pyrophosphate and Arterial Calcification in Chronic Kidney Disease

Recruiting
NCT06049771Not Applicable

The Population Pharmacokinetics Study of Tigecycline and Pharmacokinetics- Pharmacodynamics Index in Patients With Carbapenem Resistant Enterobacteriaceae Bloodstream Infection

Unknown

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3